Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cefepime (maxipeme) (6 trials)
meropenem (merrem) (2 trials)
taniborbactam (7 trials)
ceftibuten (cedax) (3 trials)
metronidazole (flagyl) (1 trial)
sulopenem etzadroxil (4 trials)
vnrx-5024 (1 trial)
vnrx-9945 (1 trial)
Bacterial Infections (Phase 1)
Communicable Diseases (Phase 3)
Infections (Phase 3)
Pyelonephritis (Phase 3)
Renal Insufficiency (Phase 1)
Urinary Tract Infections (Phase 3)
Trials (13 total)
Trial APIs (8 total)